Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-13-048246
Filing Date
2013-09-09
Accepted
2013-09-09 16:30:01
Documents
2
Period of Report
2013-08-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 - ALLEN A. FIENBERG, PH.D. rrd389839.html 3  
1 FORM 3 - ALLEN A. FIENBERG, PH.D. rrd389839.xml 3 12995
2 POWER OF ATTORNEY - ALLEN A. FIENBERG, PH.D. rrd350727_397096.htm EX-24.1 3999
  Complete submission text file 0001181431-13-048246.txt   18454
Mailing Address 3960 BROADWAY NEW YORK NY 10032
Business Address 3960 BROADWAY NEW YORK NY 10032 212-923-3344
Intra-Cellular Therapies, Inc. (Issuer) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTRA-CELLULAR THERAPIES, INC. 3960 BROADWAY NEW YORK NY 10032
Business Address
Fienberg Allen A. (Reporting) CIK: 0001585666 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-54896 | Film No.: 131085925